The nanocarrier strategy for crossing the blood-brain barrier in glioma therapy
H Wu, Y Wang, Z Ren, H Cong, Y Shen, B Yu - Chinese Chemical Letters, 2024 - Elsevier
Glioma is the most common malignant tumor of the brain. The postoperative recurrence rate
was high, and the 2-year survival rate only increased by 20%–25%. The reason is the blood …
was high, and the 2-year survival rate only increased by 20%–25%. The reason is the blood …